Things at company are going good, technical chart looking great, and I will talk to Dr. Paul on Monday. I dont need to know anything extra, but do want to verify 32.6 mill outstanding and 32.6 mill fully diluted, no dilution since Nasdeq listing in 1996. Also wanted to verify exact phase 3 start date, and get a medicine question answered on the NX-1207. The U.S. partner is very close, full enrollment is heating up, and the phase 3 approval wont take as long as you people think. These are the type of events events that will bring us Analyst coverage and the volume that can cause NYMX stock to breakout. Dont need any extra info, know two more people signing up here in Towson Maryland for the popular phase 3 study. Any help with my first 2 questions is appreciated.